| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000083597 |
| P698 | PubMed publication ID | 15812158 |
| P2093 | author name string | Carl C Schimanski | |
| Peter R Galle | |||
| Ines Gockel | |||
| Markus Moehler | |||
| Theodor Junginger | |||
| P2860 | cites work | Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction | Q28215716 |
| Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer | Q33341957 | ||
| Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). | Q34039874 | ||
| Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer | Q34190498 | ||
| A comparison of computerised tomography, laparoscopic ultrasound and endoscopic ultrasound in the preoperative staging of oesophago-gastric carcinoma | Q34520607 | ||
| Docetaxel in advanced gastric cancer | Q34667854 | ||
| Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study | Q34754369 | ||
| Classification of adenocarcinoma of the oesophagogastric junction | Q34755030 | ||
| Neoadjuvant therapy for oesophagogastric cancer | Q35762516 | ||
| Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group | Q36619190 | ||
| Neoadjuvant chemotherapy for gastric cancer: Update | Q40483576 | ||
| Neoadjuvant radio-chemotherapy of adenocarcinoma of the oesophagogastric junction | Q40696881 | ||
| Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. The Dutch Gastric Cancer Group (DGCG). | Q40797057 | ||
| Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus | Q41543455 | ||
| Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on longterm survival | Q41556061 | ||
| Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial | Q44017893 | ||
| Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia | Q44549060 | ||
| Multimodal therapy of tumors of the upper gastrointestinal tract | Q44571207 | ||
| Postoperative chemoradiotherapy for gastric cancer | Q44572707 | ||
| Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial | Q44691627 | ||
| Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma | Q44978576 | ||
| Pretherapeutic laparoscopic staging in advanced gastric carcinoma. | Q51447986 | ||
| Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. | Q53604465 | ||
| Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. | Q53610419 | ||
| Minilaparoscopy in the diagnosis of peritoneal tumor spread: prospective controlled comparison with computed tomography. | Q53622523 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 345-350 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Digestive Diseases | Q15759019 |
| P1476 | title | (Neo)adjuvant strategies of advanced gastric carcinoma: time for a change? | |
| P478 | volume | 22 |
| Q35059969 | Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy |
| Q42846225 | Coexpression of receptor-tyrosine-kinases in gastric adenocarcinoma--a rationale for a molecular targeting strategy? |
| Q64090054 | Loss of Expression Correlates with Diffuse Gastric Cancer and Distant Peritoneal Metastases |
| Q51787570 | Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome. |
| Q43058727 | Multidisciplinary management of gastric and gastroesophageal cancers |
| Q43249734 | Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication |
| Q34581435 | Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction. |
| Q92714655 | Role of CA19-9 in the prognostic evaluation of SOX neoadjuvant chemotherapy for gastric cancer |
Search more.